THB ASSET MANAGEMENT - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 160 filers reported holding ANI PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 6.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
THB ASSET MANAGEMENT ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$979,000
-28.2%
33,745
-30.3%
0.22%
-41.3%
Q3 2020$1,364,000
-18.1%
48,385
-6.1%
0.38%
-21.6%
Q2 2020$1,665,000
-22.8%
51,502
-2.8%
0.48%
-28.7%
Q1 2020$2,157,000
-61.6%
52,964
-41.8%
0.68%
-34.9%
Q4 2019$5,613,000
-11.6%
91,018
+4.5%
1.04%
-11.6%
Q3 2019$6,347,000
-13.5%
87,102
-2.5%
1.18%
+0.4%
Q2 2019$7,340,000
+309.4%
89,305
+251.2%
1.17%
+348.3%
Q1 2019$1,793,000
+58.4%
25,431
+1.1%
0.26%
+55.4%
Q4 2018$1,132,000
-20.4%
25,1560.0%0.17%
-3.4%
Q3 2018$1,422,000
-10.9%
25,156
+5.3%
0.17%
-10.8%
Q2 2018$1,596,000
+23.5%
23,898
+7.7%
0.20%
+15.4%
Q1 2018$1,292,000
-0.2%
22,193
+10.4%
0.17%
-0.6%
Q4 2017$1,295,000
+63.5%
20,101
+33.2%
0.17%
+56.0%
Q3 2017$792,000
+25.3%
15,095
+11.8%
0.11%
+32.9%
Q2 2017$632,000
+43.3%
13,505
+51.4%
0.08%
+49.1%
Q1 2017$441,000
-18.3%
8,9230.0%0.06%
-17.9%
Q4 2016$540,000
-8.8%
8,9230.0%0.07%
-23.0%
Q3 2016$592,000
+7.6%
8,923
-9.5%
0.09%
+22.5%
Q2 2016$550,0009,8620.07%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders